OLAV HELLEBO

30/08/2018
Posted in
30/08/2018 martin

Olav is an international pharmaceutical executive with particular expertise in clinical development, out-licensing, commercialisation and the marketing of new therapeutics. Currently the Chief Executive Officer of ReNeuron PLC., Olav holds an impressive track record as the previous CEO at Clavis Pharma ASA, a listed biotechnology company; the head of the UK commercial operations at Novartis; and the head of the global bio-logistics franchise at UCB Pharma. He has a Bachelor of Business Administration from Hofstra University, USA, and an MBA from the IESE Business School.